Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET. Company Participants. Camilla Zuckero - VP, IR and Corporate Affairs Derek Ma ...
Innovation Works' AlphaLab accelerator named its first ever unified cohort. Selected companies will receive up to $100,000 in ...
Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 –– Biomarker ...
Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...
Learn more about whether Amicus Therapeutics, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Precision BioSciences (NASDAQ:DTIL) added ~6% in the premarket on Wednesday after the gene therapy developer announced ...
Arcus Biosciences (NYSE:RCUS) shares dipped 4% after the company priced a stock offering to raise approximately $150 million. The offering consists of 13,636,364 shares of common stock issued at ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...
To watch Dr. Amit Kumar's full interview on Alpha Wolf Trading, please visit: . About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and ...